These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22544896)

  • 21. Tiotropium and simplified detection of dynamic hyperinflation.
    Gelb AF; Taylor CF; McClean PA; Shinar CM; Rodrigues MT; Gutierrez CA; Chapman KR; Zamel N
    Chest; 2007 Mar; 131(3):690-695. PubMed ID: 17356081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restrictive spirometric pattern in the general adult population: Methods of defining the condition and consequences on prevalence.
    Backman H; Eriksson B; Hedman L; Stridsman C; Jansson SA; Sovijärvi A; Lindberg A; Rönmark E; Lundbäck B
    Respir Med; 2016 Nov; 120():116-123. PubMed ID: 27817808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial.
    Hanania NA; Sharafkhaneh A; Celli B; Decramer M; Lystig T; Kesten S; Tashkin D
    Respir Res; 2011 Jan; 12(1):6. PubMed ID: 21219660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Responses of FEV6, FVC, and FET to inhaled bronchodilator in the adult general population.
    Kainu A; Lindqvist A; Sarna S; Lundbäck B; Sovijärvi A
    Respir Res; 2009 Jul; 10(1):71. PubMed ID: 19638220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing bronchodilator response by changes in per cent predicted forced expiratory volume in one second.
    Ioachimescu OC; Ramos JA; Hoffman M; McCarthy K; Stoller JK
    J Investig Med; 2021 Jun; 69(5):1027-1034. PubMed ID: 33574095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in clinical significance of bronchodilator responses measured by forced expiratory volume in 1 second and forced vital capacity.
    Choi JY; Kim SK; Lee JH; Jung KS; Yoo KH; Hwang KE; Lee JD; Kim YI; Yoon HK; Um SJ
    PLoS One; 2023; 18(2):e0282256. PubMed ID: 36827406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of bronchodilator use on the prevalence of COPD in population-based samples.
    Pérez-Padilla R; Hallal PC; Vázquez-García JC; Muiño A; Máquez M; López MV; de Oca MM; Tálamo C; Valdivia G; Pertuzé J; Jardim J; Menezes AM;
    COPD; 2007 Jun; 4(2):113-20. PubMed ID: 17530504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substantial variation exists in spirometry interpretation practices for airflow obstruction in accredited lung function laboratories across Australia and New Zealand.
    Holt NR; Thompson BR; Miller B; Borg BM
    Intern Med J; 2019 Jan; 49(1):41-47. PubMed ID: 30043534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease.
    Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD
    Clin Physiol Funct Imaging; 2012 Jan; 32(1):12-8. PubMed ID: 22152074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of bronchodilator responsiveness of the small airway (using mid-maximal expiratory flow) in COPD - a retrospective study.
    Alobaidi NY; Almeshari MA; Stockley JA; Stockley RA; Sapey E
    BMC Pulm Med; 2022 Dec; 22(1):493. PubMed ID: 36585669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis.
    Assayag D; Vittinghoff E; Ryerson CJ; Cocconcelli E; Tonelli R; Hu X; Elicker BM; Golden JA; Jones KD; King TE; Koth LL; Lee JS; Ley B; Shum AK; Wolters PJ; Ryu JH; Collard HR
    Respir Med; 2015 Aug; 109(8):1058-62. PubMed ID: 26140806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small airways obstruction and its risk factors in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study.
    Knox-Brown B; Patel J; Potts J; Ahmed R; Aquart-Stewart A; Cherkaski HH; Denguezli M; Elbiaze M; Elsony A; Franssen FME; Ghobain MA; Harrabi I; Janson C; Jõgi R; Juvekar S; Lawin H; Mannino D; Mortimer K; Nafees AA; Nielsen R; Obaseki D; Paraguas SNM; Rashid A; Loh LC; Salvi S; Seemungal T; Studnicka M; Tan WC; Wouters EEFM; Barbara C; Gislason T; Gunasekera K; Burney P; Amaral AFS;
    Lancet Glob Health; 2023 Jan; 11(1):e69-e82. PubMed ID: 36521955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
    Kim J; Kim WJ; Lee CH; Lee SH; Lee MG; Shin KC; Yoo KH; Lee JH; Lim SY; Na JO; Hwang HG; Hong Y; Lim MN; Yoo CG; Jung KS; Lee SD
    Respir Res; 2017 May; 18(1):107. PubMed ID: 28558829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchodilator response in patients with normal baseline spirometry.
    Hegewald MJ; Townsend RG; Abbott JT; Crapo RO
    Respir Care; 2012 Oct; 57(10):1564-70. PubMed ID: 22417788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant bronchodilator responsiveness and "reversibility" in a population sample.
    Prentice HA; Mannino DM; Caldwell GG; Bush HM
    COPD; 2010 Oct; 7(5):323-30. PubMed ID: 20854046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Argument for changing criteria for bronchodilator responsiveness.
    Hansen JE; Sun XG; Adame D; Wasserman K
    Respir Med; 2008 Dec; 102(12):1777-83. PubMed ID: 18701269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.
    Richter DC; Joubert JR; Nell H; Schuurmans MM; Irusen EM
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):693-9. PubMed ID: 19281083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care.
    Schermer TR; Smeele IJ; Thoonen BP; Lucas AE; Grootens JG; van Boxem TJ; Heijdra YF; van Weel C
    Eur Respir J; 2008 Oct; 32(4):945-52. PubMed ID: 18550607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
    Pirozzi CS; Gu T; Quibrera PM; Carretta EE; Han MK; Murray S; Cooper CB; Tashkin DP; Kleerup EC; Barjaktarevic I; Hoffman EA; Martinez CH; Christenson SA; Hansel NN; Graham Barr R; Bleecker ER; Ortega VE; Martinez FJ; Kanner RE; Paine R;
    Respir Res; 2018 Nov; 19(1):223. PubMed ID: 30454050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.